The global Glabridin market was valued at US$ 37.74 million in 2024 and is anticipated to reach US$ 59.43 million by 2031, witnessing a CAGR of 6.84% during the forecast period 2025-2031.
North American market for Glabridin is estimated to increase from $5.96 million in 2024 to reach $9.20 million by 2031, at a CAGR of 6.35% during the forecast period of 2024 through 2031.
Asia-Pacific market for Glabridin is estimated to increase from $21.09 million in 2024 to reach $33.86 million by 2031, at a CAGR of 7.17% during the forecast period of 2024 through 2031.
The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glabridin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glabridin.
The Glabridin market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glabridin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glabridin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss
Segment by Type
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Segment by Application
Creams and Lotions
Masks
Sunscreen Products
Others
Consumption by Region
North America
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook